ArticleDisease markers2014

The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation.

Samantha J Brunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.